Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;15(6):633-40.
doi: 10.1038/nm.1968.

Prostaglandin E2-EP4 Signaling Promotes Immune Inflammation Through Th1 Cell Differentiation and Th17 Cell Expansion

Affiliations

Prostaglandin E2-EP4 Signaling Promotes Immune Inflammation Through Th1 Cell Differentiation and Th17 Cell Expansion

Chengcan Yao et al. Nat Med. .

Abstract

Two distinct helper T (TH) subsets, TH1 and TH17, mediate tissue damage and inflammation in animal models of various immune diseases such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases and allergic skin disorders. These experimental findings, and the implication of these TH subsets in human diseases, suggest the need for pharmacological measures to manipulate these TH subsets. Here we show that prostaglandin E2 (PGE2) acting on its receptor EP4 on T cells and dendritic cells not only facilitates TH1 cell differentiation but also amplifies interleukin-23-mediated TH17 cell expansion in vitro. Administration of an EP4-selective antagonist in vivo decreases accumulation of both TH1 and TH17 cells in regional lymph nodes and suppresses the disease progression in mice subjected to experimental autoimmune encephalomyelitis or contact hypersensitivity. Thus, PGE2-EP4 signaling promotes immune inflammation through TH1 differentiation and TH17 expansion, and EP4 antagonism may be therapeutically useful for various immune diseases.

Similar articles

See all similar articles

Cited by 167 articles

See all "Cited by" articles

References

    1. Biochem J. 2003 Apr 1;371(Pt 1):15-27 - PubMed
    1. J Exp Med. 2007 Aug 6;204(8):1849-61 - PubMed
    1. J Clin Invest. 2001 Oct;108(8):1229-35 - PubMed
    1. J Exp Med. 2009 Mar 16;206(3):535-48 - PubMed
    1. J Immunol. 1983 Aug;131(2):768-72 - PubMed

Publication types

MeSH terms

Feedback